ISRCTN98702137
Completed
Not Applicable
Randomised, prospective double-blind, placebo-controlled study to evaluate the effect of antioxidant therapy in preventing kidney damage caused by lithotripsy
Reina Sofia Universitary Hospital (Spain)0 sites126 target enrollmentMarch 10, 2010
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Kidney stone disease treated by extracorporeal shockwave lithotripsy
- Sponsor
- Reina Sofia Universitary Hospital (Spain)
- Enrollment
- 126
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients \> 18 yr with renal stones scheduled to be treated by extracorporeal shockwave lithotripsy
Exclusion Criteria
- •1\. Any contraindication for lithotripsy.
- •2\. Patients undergoing lithotripsy at the time of initiating the study
- •3\. Severe impairment of treated kidney
- •4\. Complications related to lithotripsy that need of an interventional procedure during the study period
- •5\. Inability to understand or psychosocial maladjustment
- •6\. Refusal to sign the informed consent form
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Meperidine versus valethamate bromide in shortening the duration of laborShortening the duration of laborReproductive Health and Childbirth - Childbirth and postnatal careReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12609000153213Dr Sefa Kelekci39
Recruiting
Not Applicable
Comparative study of the effect of the intervention of real Transcranial Led Therapy and placebo, on anxiety and depression with patients with TBI.Craniocerebral Trauma, anxiety, depression, Pathological conditions, signs and symptoms, Low-Level Light TherapyC10.900.300F01.470.132F01.145.126.350E02.594.540RBR-8jcwjpCentro Universitário UniFacid
Active, not recruiting
Not Applicable
Prospective clinical study, where patients are receiving or the study drug or an inactive drug called placebo wihtout knowing which of the two drugs is taken, even the Investigator is aware of the therapy taken by the patients. Patients are assigned to a specific treatment according to a randomization list. The study is performed to assess the effects and tolerability of K(D)PT in ulcerative colitis.mild to moderate ulcerative colitisMedDRA version: 14.1Level: SOCClassification code 10017947Term: Gastrointestinal disordersSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2011-002462-20-ITDR. AUGUST WOLFF GMBH & CO. KG160
Active, not recruiting
Not Applicable
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisEUCTR2011-002462-20-PLDr August Wolff GmbH & Co KG Arzneimittel160
Active, not recruiting
Not Applicable
Clinical trial to evaluate the efficacy and safety of K(D)PT in patients with mild to moderate ulcerative colitisEUCTR2011-002462-20-HUDr August Wolff GmbH & Co KG Arzneimittel